Malaysian hospital operator Asia OneHealthcare has taken a step toward a public listing, filing draft IPO papers with the Securities Commission Malaysia. The company is seeking to sell up to 4.38 billion shares, a move that would mark one of the larger healthcare listings in the region this year.
The filing comes after the company swung to a profit of 344.4 million ringgit (about $73 million) for the year ended March 2026, a sharp turnaround from a loss in the prior year. Revenue rose 13.6% to 3.29 billion ringgit, helped by higher patient volumes and expanded services across its network.
What's in the deal?
The proposed listing is structured in two main parts. Up to 3.86 billion existing shares would be sold by HLT Healthcare Holdings Singapore, a vehicle controlled by private equity firm TPG. In addition, the company would issue 521.1 million new shares, which would bring fresh capital onto its balance sheet.
Most of the shares are earmarked for institutional investors, with a smaller pool set aside for staff and the Malaysian public. There is also an over-allotment option for up to 657.1 million additional existing shares, which could increase the total selldown if exercised.
If the over-allotment is not used, HLT would still own 73.9% of the company after the IPO. That means the listing is primarily an ownership transfer rather than a major fundraising event. Only the new shares—about 12% of the maximum offering—would generate proceeds for the company itself.
The draft prospectus does not include a price, a fundraising target, or a listing date. However, Reuters reported earlier this year that TPG had hired Maybank and UBS to explore a local listing that could value the business at around 30 billion ringgit.
Who is Asia OneHealthcare?
Asia OneHealthcare operates 23 hospitals—22 in Malaysia and one in Vietnam. The company says proceeds from the new shares would be used for expansion, upkeep and equipment, partial debt repayment, and fees. That suggests the fresh capital is intended to support growth plans, though the relatively small new-issue portion means the company may still rely on cash flow and borrowing for larger investments.
The filing adds to a busy period for Malaysian IPOs. Big Caring's IPO and MYDCD's planned listing are among recent deals, while the broader market has seen mixed sentiment. The FBM KLCI has been volatile, and investors are watching for signs of sustained demand for new listings.
What it means for investors
For everyday investors, the key takeaway is that this IPO is more about TPG selling down its stake than about raising big money for the company. Secondary-heavy deals can behave differently in early trading. With a relatively limited new float, price moves may reflect how tightly institutional investors hold their allocations, rather than just the company's fundamentals.
Another factor to watch is the over-allotment option. If exercised, it would increase the number of shares available, potentially adding supply. And with HLT still controlling a large majority, investors will likely keep an eye on potential future selldowns, which could affect sentiment and share price over time.
For those considering participating, it's important to note that the company's turnaround is real—revenue is growing and it has moved from a loss to a profit. But the healthcare sector in Malaysia is competitive, and expansion plans will depend on execution. As with any IPO, the lack of a price means valuation is still unknown, and investors should wait for the final terms before making any decisions.
The listing also highlights the ongoing interest in healthcare assets in Southeast Asia. Private equity owners often use IPOs as an exit route, and this deal could set a benchmark for other hospital operators in the region. Other consumer and healthcare companies have also filed for listings recently, suggesting a healthy pipeline of new issues.
For now, the market will be watching for the pricing and the final size of the offering. Those details will give a clearer picture of how much demand there is for Asia OneHealthcare's shares and what the company's growth prospects are worth.
